Bhagwan Devi Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and trading various products since 2016 in Sonepat, Haryana.
2016 | Sonipat, Haryana (India) | Active
Bhagwan Devi Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.00 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 38.41%
- Profit Growth 97.94%
- Ebitda -14.29%
- Net Worth -0.32%
- Total Assets 2.58%
About Bhagwan Devi Pharmaceuticals
Bhagwan Devi Pharmaceuticals Private Limited (BDPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 January 2016 (Nine years and one month 14 days old ). Its registered office is in Sonipat, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Chander Mohan, Sunita Kalara, Monika, and One other member serve as directors at the Company.
Company Details
- Location
Sonipat, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100HR2016PTC057975
- Company No.
057975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Bhagwan Devi Pharmaceuticals Private Limited
Explore comprehensive data for Bhagwan Devi Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Bhagwan Devi Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Mohan  | Director | 10-Feb-2016 | Current |
| Sunita Kalara | Director | 27-Jan-2016 | Current |
| Monika | Director | 24-Jan-2017 | Current |
| Manoj Kalra | Director | 27-Jan-2016 | Current |
Financial Performance of Bhagwan Devi Pharmaceuticals.
Bhagwan Devi Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.41% increase. The company also saw a substantial improvement in profitability, with a 97.94% increase in profit. The company's net worth dipped by a decrease of 0.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhagwan Devi Pharmaceuticals?
In 2022, Bhagwan Devi Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Chemistaa India Private Limited
Chander Mohan and Manoj Kalra are mutual person
- Research Medicine Private Limited
Chander Mohan and Manoj Kalra are mutual person
- Rescare Pharmaceuticals Private Limited
Chander Mohan and Manoj Kalra are mutual person
- Oribelle Cosmetics Private Limited
Sunita Kalara and Manoj Kalra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhagwan Devi Pharmaceuticals?
Unlock and access historical data on people associated with Bhagwan Devi Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhagwan Devi Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhagwan Devi Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bhagwan Devi Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Bhagwan Devi Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Bhagwan Devi Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Director Appointment
Monika was appointed as a Director was appointed as a Director on 24 Jan 2017 & has been associated with this company since 8 years 1 month .
- Director Appointment
Chander Mohan was appointed as a Director was appointed as a Director on 10 Feb 2016 & has been associated with this company since 9 years 1 month .
- Director Appointment
Sunita Kalara was appointed as a Director was appointed as a Director on 27 Jan 2016 & has been associated with this company since 9 years 1 month .
- Director Appointment
Manoj Kalra was appointed as a Director was appointed as a Director on 27 Jan 2016 & has been associated with this company since 9 years 1 month .
Frequently asked questions
What is the Incorporation or founding date of Bhagwan Devi Pharmaceuticals Private Limited?
Bhagwan Devi Pharmaceuticals Private Limited was incorporated on 27 Jan 2016.
What is authorized share capital and paid-up capital of Bhagwan Devi Pharmaceuticals Private Limited?
The authorized share capital of Bhagwan Devi Pharmaceuticals Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.00 M.
Who are the current board members & directors of Bhagwan Devi Pharmaceuticals Private Limited?
Currently 4 directors are associated with Bhagwan Devi Pharmaceuticals Private Limited.
- Chander Mohan
- Sunita Kalara
- Monika
- Manoj Kalra
What is the registered address of Bhagwan Devi Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bhagwan Devi Pharmaceuticals Private Limited is Plot No. 1599 Industrial Estate Hsiidc, Rai India, Sonepat, Haryana, 131029.
What is the corporate identification number (CIN) and company number of Bhagwan Devi Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Bhagwan Devi Pharmaceuticals Private Limited is U24100HR2016PTC057975 and the company number is 057975 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Bhagwan Devi Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Bhagwan Devi Pharmaceuticals Private Limited has risen by 38.41%.
What change has been observed in the net worth of Bhagwan Devi Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Bhagwan Devi Pharmaceuticals Private Limited has experienced an downturn of -0.32%.
When was the last Balance Sheet of Bhagwan Devi Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Bhagwan Devi Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records